Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

SELL
$9.95 - $12.27 $20,069 - $24,748
-2,017 Closed
0 $0
Q1 2022

Apr 20, 2022

BUY
$9.81 - $15.4 $2,668 - $4,188
272 Added 15.59%
2,017 $21,000
Q4 2021

Jan 21, 2022

SELL
$12.09 - $14.68 $1,462 - $1,776
-121 Reduced 6.48%
1,745 $24,000
Q3 2021

Oct 19, 2021

BUY
$13.25 - $15.13 $6,227 - $7,111
470 Added 33.67%
1,866 $25,000
Q2 2021

Jul 23, 2021

BUY
$12.97 - $16.15 $3,164 - $3,940
244 Added 21.18%
1,396 $20,000
Q1 2021

Apr 20, 2021

BUY
$13.59 - $18.54 $1,576 - $2,150
116 Added 11.2%
1,152 $16,000
Q4 2020

Jan 28, 2021

BUY
$14.3 - $18.74 $14,814 - $19,414
1,036 New
1,036 $19,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Gemmer Asset Management LLC Portfolio

Follow Gemmer Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gemmer Asset Management LLC with notifications on news.